Computed Tomography Features associated With the Eighth Edition TNM Stage Classification for Thymic Epithelial Tumors
Sukhmani K. Padda(Stanford University), Heather A. Wakelee(Palo Alto Institute), Amanda Khuong, Joel W. Neal(Stanford Medicine), Ann N. Leung(Stanford Medicine), Jonathan W. Riess(University of California Davis Medical Center), Joseph B. Shrager(Stanford Medicine), Chuong D. Hoang(National Institutes of Health), Donato Terrone, Erich Schwartz(Stanford Medicine), Lü Tian(Shandong University), Mark F. Berry(Stanford Medicine), Bryan M. Burt(Baylor College of Medicine)
Cited by 19
Related Papers
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
|The Lancet|2021|1.5k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%
|Journal of Clinical Oncology|2021|1.1k
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2023|1k
Non–Small Cell Lung Cancer, Version 4.2024
|Journal of the National Comprehensive Cancer Network|2024|805